The pharma manufacturer Moderna says their vaccine against the coronavirus is also very effective for people under 18 years of age.
Children as young as 12 can be protected against COVID-19 with the vaccine, the New York Times writes.
The company will now apply for approval for the use of the vaccine in this age group in the United States.
If approved, it will be the second COVID-19 vaccine to be given to children and adolescents under the age of 18 in the United States.
Pfizer and Biontech’s vaccine, which was first approved for everyone aged 16 and up, was approved earlier this month for use on people under 12 years of age.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at [email protected]
Be the first to comment on "New York Times: Moderna’s corona vaccine effective for children as young as 12"